179 related articles for article (PubMed ID: 29516208)
21. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients.
Bani-Hani AH; Leibovich BC; Lohse CM; Cheville JC; Zincke H; Blute ML
J Urol; 2005 Feb; 173(2):391-4. PubMed ID: 15643178
[TBL] [Abstract][Full Text] [Related]
22. Tumor-parenchyma interface and long-term oncologic outcomes after robotic tumor enucleation for sporadic renal cell carcinoma.
Minervini A; Campi R; Di Maida F; Mari A; Montagnani I; Tellini R; Tuccio A; Siena G; Vittori G; Lapini A; Raspollini MR; Carini M
Urol Oncol; 2018 Dec; 36(12):527.e1-527.e11. PubMed ID: 30268711
[TBL] [Abstract][Full Text] [Related]
23. Contralateral metachronous tumor occurrence is more frequently associated with distant metastases or postoperative intrarenal recurrence in renal cell carcinoma patients.
Amano H; Kondo T; Hashimoto Y; Kobayashi H; Iizuka J; Shimada K; Nakazawa H; Ito F; Tanabe K
Int J Urol; 2010 Jul; 17(7):615-22. PubMed ID: 20482658
[TBL] [Abstract][Full Text] [Related]
24. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.
Santoni M; Conti A; Partelli S; Porta C; Sternberg CN; Procopio G; Bracarda S; Basso U; De Giorgi U; Derosa L; Rizzo M; Ortega C; Massari F; Iacovelli R; Milella M; Di Lorenzo G; Buti S; Cerbone L; Burattini L; Montironi R; Santini D; Falconi M; Cascinu S
Ann Surg Oncol; 2015; 22(6):2094-100. PubMed ID: 25472645
[TBL] [Abstract][Full Text] [Related]
25. Radiologic follow-up of patients with T1-3a,b,c or T4N+M0 renal cell carcinoma after radical nephrectomy.
Saidi JA; Newhouse JH; Sawczuk IS
Urology; 1998 Dec; 52(6):1000-3. PubMed ID: 9836544
[TBL] [Abstract][Full Text] [Related]
26. Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma.
Russell CM; Lue K; Fisher J; Kassouf W; Schwaab T; Sexton WJ; Tanguay S; Psutka SP; Thompson RH; Leibovich BC; Hanzly MI; Spiess PE; Boorjian SA
BJU Int; 2016 Jun; 117(6B):E60-6. PubMed ID: 26118331
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH
AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359
[TBL] [Abstract][Full Text] [Related]
28. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome.
Cheville JC; Lohse CM; Sukov WR; Thompson RH; Leibovich BC
Am J Surg Pathol; 2012 Jun; 36(6):851-6. PubMed ID: 22367296
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.
Kuthi L; Jenei A; Hajdu A; Németh I; Varga Z; Bajory Z; Pajor L; Iványi B
Pathol Oncol Res; 2017 Jul; 23(3):689-698. PubMed ID: 28032311
[TBL] [Abstract][Full Text] [Related]
30. Gender as a prognostic factor in patients with renal cell carcinoma.
Onishi T; Oishi Y; Goto H; Yanada S; Abe K
BJU Int; 2002 Jul; 90(1):32-6. PubMed ID: 12081765
[TBL] [Abstract][Full Text] [Related]
31. [A case of late perirenal fat recurrence after partial nephrectomy for T1A renal cell carcinoma].
Fukui T; Yamasaki T; Mizuno K; Negoro H; Kobayashi T; Terada N; Sugino Y; Matsui Y; Inoue T; Kamba T; Yoshimura K; Ogawa O
Hinyokika Kiyo; 2014 Oct; 60(10):481-3. PubMed ID: 25391777
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
33. Features, risk factors and clinical outcome of "very late" recurrences after surgery for localized renal carcinoma: A retrospective evaluation of a cohort with a minimum of 10 years of follow up.
Antonelli A; Furlan M; Sodano M; Cindolo L; Belotti S; Tardanico R; Cozzoli A; Zanotelli T; Simeone C
Int J Urol; 2016 Jan; 23(1):36-40. PubMed ID: 26567050
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes.
Haddad MM; Schmit GD; Kurup AN; Schmitz JJ; Boorjian SA; Geske J; Thompson RH; Callstrom MR; Atwell TD
J Vasc Interv Radiol; 2018 Aug; 29(8):1122-1126. PubMed ID: 29887184
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma.
Büscheck F; Fraune C; Simon R; Kluth M; Hube-Magg C; Möller-Koop C; Shadanpour N; Bannenberg C; Eichelberg C; Höflmayer D; Clauditz T; Wittmer C; Wilczak W; Sauter G; Fisch M; Rink M; Eichenauer T
Urol Oncol; 2018 Dec; 36(12):531.e19-531.e25. PubMed ID: 30322727
[TBL] [Abstract][Full Text] [Related]
36. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
37. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysis.
Syed JS; Nguyen KA; Holford TR; Hofmann JN; Shuch B
Cancer; 2019 Jan; 125(2):232-238. PubMed ID: 30561791
[TBL] [Abstract][Full Text] [Related]
39. Incidence of Clear Cell Papillary Renal Cell Carcinoma in Low-Grade Renal Cell Carcinoma Cases: A 12-Year Retrospective Clinicopathologic Study From a Single Cancer Center.
Gill S; Kauffman EC; Kandel S; George S; Schwaab T; Xu B
Int J Surg Pathol; 2016 May; 24(3):207-12. PubMed ID: 26510859
[TBL] [Abstract][Full Text] [Related]
40. [Local recurrence of renal cell carcinoma after nephrectomy].
Pereverzev AS; Shchukin DV; Iliukhin IuA
Urologiia; 2003; (6):14-8. PubMed ID: 14708237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
